Bolstering the Evidence Base for Integrating Abortion and HIV Care: A Literature Review

Table 3

Studies summarizing data on blood loss due to medication abortion in India.

Authors	Study type	Setting	Population	Number	Medication abortion regimen	Findings
Coyaji et al. (2002) [33]	Prospective	India, urban and rural hospitals	Pregnant women with gestations of ≤63 days in the urban sites and ≤56 days in the rural site	900	600 mg mifepristone and 400 𝜇g misoprostol; oral	Mean change in hemoglobin levels 0.1–0.2 gm/dL
Elul et al. (1999) [31]	Retrospective	India, urban hospital	Pregnant women with amenorrhea ≤56 days	250	600 mg mifepristone and 400 𝜇g misoprostol; oral	Mean change in hemoglobin levels −0.29 gm/dL
Harper et al. (1998) [29]	Prospective	India, urban hospital	Pregnant women with amenorrhea ≤56 days	250	600 mg mifepristone and 400 𝜇g misoprostol; oral	4% of women experienced drop in hemoglobin levels >2 gm/dL
Mundle et al. (2007) [32]	Prospective	India, primary health care center	Pregnant women with amenorrhea ≤56 days	149	200 mg mifepristone and 400 𝜇g misoprostol; sublingual	Median change in hemoglobin levels 0.1 gm/dL; no serious complications
Winikoff et al. (1997) [30]	Prospective	India, urban hospital	Pregnant women with amenorrhea ≤56 days	250	600 mg mifepristone and 400 𝜇g misoprostol; oral	Mean change in hemoglobin levels −0.29 gm/dL; 1.2% of women experienced drop >2 gm/dL